CPRX$1.66 のグッド・ニュース
Catalyst Pharmaceuticals Inc (CPRX) PT Set at $3.00 by Roth Capital
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) has been given a $3.00 target price by Roth Capital in a report released on Monday. The brokerage presently has a “buy” rating on the biopharmaceutical company’s stock. Roth Capital’s target price suggests a

CPRXは＄1.60で買い！
BIOCも＄2.10で買い増し。
PLXも＄1.10で買い増し。

CERUはDamp株。少量保有で良かった、、、

明日、Fund loadedを願って。